31 results on '"Ernst Jan"'
Search Results
2. Abstract 3744: Differential Orthopedia Homeobox (OTP) expression in pulmonary carcinoids is associated with changes in DNA methylation
- Author
-
Moonen, Laura, primary, Mangiante, Lise, additional, Leunissen, Daphne J., additional, Lap, Lisa M., additional, Gabriel, Aurelie, additional, Hillen, Lisa M., additional, Roemen, Guido M., additional, Koch, Alexander, additional, van Engeland, Manon, additional, Dingemans, Anne-Marie C., additional, Foll, Matthieu, additional, Alcala, Nicolas, additional, Fernandez-Cuesta, Lynnette, additional, Derks, Jules L., additional, and Speel, Ernst-Jan M., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Abstract 2229: Targeted locus amplification based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas
- Author
-
Demers, Imke, primary, Balaji, Harini, additional, Feitsma, Harma, additional, Sergeeva, Irinia, additional, Swennenhuis, Joost, additional, Wuerdemann, Nora, additional, Wagner, Steffen, additional, Kremer, Bernd, additional, Huebbers, Christian, additional, Klussmann, Jens Peter, additional, and Speel, Ernst-Jan, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Abstract 3744: Differential Orthopedia Homeobox (OTP) expression in pulmonary carcinoids is associated with changes in DNA methylation
- Author
-
Laura Moonen, Lise Mangiante, Daphne J. Leunissen, Lisa M. Lap, Aurelie Gabriel, Lisa M. Hillen, Guido M. Roemen, Alexander Koch, Manon van Engeland, Anne-Marie C. Dingemans, Matthieu Foll, Nicolas Alcala, Lynnette Fernandez-Cuesta, Jules L. Derks, and Ernst-Jan M. Speel
- Subjects
Cancer Research ,Oncology - Abstract
Introduction: Limited number of tumor types have been examined for Orthopedia Homeobox (OTP) expression. In pulmonary carcinoids, loss of expression is a strong indicator of poor prognosis. Here, we investigated OTP expression in 37 different tumor types, and the association between OTP expression and DNA methylation levels in lung neuroendocrine neoplasms. Methods: We analyzed publicly available multi-omics data (whole-exome-, whole-genome-, RNA sequencing, Epic-850K-methylation array) of 58 typical-, 27 atypical carcinoids, 69 large cell neuroendocrine carcinoma and 51 small cell lung cancer patients and TCGA (The Cancer Genome Atlas) data of 33 tumor types. 850K-methylation analysis was cross validated using targeted pyrosequencing on 35 carcinoids. Results: Results showed bimodality of OTP expression in carcinoids (OTPhigh versus OTPlow group, likelihood-ratio test p=1.5x10-2), with the OTPhigh group specific to pulmonary carcinoids while absent from all other cohorts analyzed. Significantly different DNA methylation levels were observed between OTPhigh and OTPlow carcinoids in 12/34 OTP infinium probes (fdr0.2). Overall, OTPlow carcinoids harbor a high DNA methylation level as compared to OTPhigh carcinoids. OTPlow carcinoids showed a significantly worse overall survival (logrank test p=0.0052). Gene set enrichment analysis for somatically mutated genes associated with hallmarks of cancer showed robust enrichment of three hallmarks in the OTPlow group, i.e., sustaining proliferative signaling, evading growth suppressor, and genome instability and mutation. Conclusion: High OTP expression is a unique feature of pulmonary carcinoids with a favorable prognosis. In poor prognostic patients, OTP expression is lost, most likely due to changes in DNA methylation levels. Citation Format: Laura Moonen, Lise Mangiante, Daphne J. Leunissen, Lisa M. Lap, Aurelie Gabriel, Lisa M. Hillen, Guido M. Roemen, Alexander Koch, Manon van Engeland, Anne-Marie C. Dingemans, Matthieu Foll, Nicolas Alcala, Lynnette Fernandez-Cuesta, Jules L. Derks, Ernst-Jan M. Speel. Differential Orthopedia Homeobox (OTP) expression in pulmonary carcinoids is associated with changes in DNA methylation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3744.
- Published
- 2022
5. Abstract 2229: Targeted locus amplification based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas
- Author
-
Imke Demers, Harini Balaji, Harma Feitsma, Irinia Sergeeva, Joost Swennenhuis, Nora Wuerdemann, Steffen Wagner, Bernd Kremer, Christian Huebbers, Jens Peter Klussmann, and Ernst-Jan Speel
- Subjects
Cancer Research ,Oncology - Abstract
Background: Human papillomavirus (HPV) infections are the principal cause of cervical cancers, subsets of anogenital and head and neck cancers (HNC). During persistent infection, viral DNA integration into the host genome may occur, which is suggested to affect carcinogenesis. One of the most critical limitations of currently used HPV integration detection techniques (PCR-based or NGS-based) is their application to FFPE material, because of DNA fragmentation. The aim of this study was to assess HPV integration in HPV-positive HNSCC cell lines and FFPE tissue comparing the new Targeted Locus Amplification (TLA) technology with previously used PCR technology (APOT/DIPS). Methods: Seven HPV-positive cell lines and FFPE material of 10 HPV-positive HNSCC were used for HPV integration detection by TLA, a proximity ligation-based next-generation sequencing technique. Crosslinked DNA is digested with restriction enzymes, and re-ligated into chimeric DNA molecules. For cell lines, a PCR based HPV16 target enrichment is performed, and for FFPE material a capture-based target enrichment is performed for HPV16 and HPV18 sequences, both followed by Illumina sequencing. Results: TLA was able to sequence up to 100 kb around the target, detecting exact HPV integration loci, structural variants, and chromosomal rearrangements. In all cell lines, one or more integration sites were identified, in accordance with APOT/DIPS PCR data and the literature. In the FFPE tissue samples, TLA identified integrated HPV in 6 out of 10 tumors, with simple and complex integration patterns. In general, TLA confirmed PCR data and detected additional integration sites. Conclusion: TLA provides the opportunity for reliable and robust detection of HPV integration in HNSCC cell lines and FFPE tissue. This new sequencing technology could be a useful tool for further research on HPV integration in disease and patient outcome and eventually in clinical diagnostics. Citation Format: Imke Demers, Harini Balaji, Harma Feitsma, Irinia Sergeeva, Joost Swennenhuis, Nora Wuerdemann, Steffen Wagner, Bernd Kremer, Christian Huebbers, Jens Peter Klussmann, Ernst-Jan Speel. Targeted locus amplification based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2229.
- Published
- 2022
6. Abstract 2573: PI3K/AKT/mTOR pathway and CDK4/6 inhibitors efficiently inhibit cell growth of HPV-positive and HPV-negative head and neck squamous cell carcinoma in vitro
- Author
-
Imke Demers, Femke Verhees, Dion Leegemaate, Robin Jacobs, Ann Hoeben, Frank Hoebers, Bernd Kremer, and Ernst-Jan Speel
- Subjects
Cancer Research ,Oncology - Abstract
Introduction: Both HPV-positive and -negative head and neck squamous cell carcinoma (HNSCC) often show activation of the PI3K/AKT/mTOR pathway, due to, amongst others, PI3KCA mutations, PTEN loss, or receptor tyrosine kinase activation. In HPV-negative tumors, CDKN2A (p16) inactivation or CCND1 (cyclin D1) amplification frequently occurs resulting in sustained cyclin dependent kinase (CDK) 4/6 activation. The aim of our study was to investigate the efficacy of PI3K/AKT/mTOR pathway inhibitors (PI3Ki) (alpelisib, buparlisib and gedatolisib) and CDK4/6 inhibitors (CDKi) (palbociclib and ribociclib) in HPV-positive and -negative HNSCC cell lines. Methods: The efficacy of the inhibitors was assessed using MTT assays and changes in PI3K and Cyclin D1/CDK pathway protein expression were determined by Western blotting. Cell cycle analysis was performed with flow cytometry and apoptosis was assessed by Annexin-V staining. Changes in cell metabolism were assessed by Seahorse XF assays. Results: Both HPV-positive and -negative HNSCC cell lines were highly sensitive to the PI3Ki (Gedatolisib, IC50 5-30 nM > Buparlisib, IC50 0.6-3.6 µM > Alpelisib, IC50 3-23 µM). In general, PI3Ki decreased pathway activity, resulted in moderate cell cycle arrest and apoptosis, and decreased oxidative and glycolytic metabolism. CDKi were particularly effective in blocking HPV-negative cell line growth (Palbociclib, IC50 0.5-2 µM > Ribociclib, IC50 4-7 µM). CDK inhibition showed decreased pRb expression and G1 cell cycle arrest, whereas apoptosis was not induced. Conclusion: PI3Ki and CDKi efficiently inhibit their respective pathways and HNSCC cell growth in vitro, the latter only in HPV-negative cell lines. Whereas PI3Ki especially show an effect on oxidative and glycolytic metabolism, CDKi particularly lead to cell cycle arrest. Further research should elucidate whether these inhibitors may be effective therapeutic agents in HNSCC patients. Citation Format: Imke Demers, Femke Verhees, Dion Leegemaate, Robin Jacobs, Ann Hoeben, Frank Hoebers, Bernd Kremer, Ernst-Jan Speel. PI3K/AKT/mTOR pathway and CDK4/6 inhibitors efficiently inhibit cell growth of HPV-positive and HPV-negative head and neck squamous cell carcinoma in vitro [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2573.
- Published
- 2022
7. Abstract 487: A high percentage of LCNEC shows DLL3 expression in association with molecular subtypes and neuroendocrine markers
- Author
-
Ernst-Jan M. Speel, Ronald A.M. Damhuis, B. Hermans, Erik Thunnissen, Anne-Marie C. Dingemans, Egbert F. Smit, Michael A. den Bakker, Cecile M. Stallinga, Guido M.J.M. Roemen, Harry J.M. Groen, Robert-Jan van Suylen, Esther C. van den Broek, and Jules L. Derks
- Subjects
clone (Java method) ,Cancer Research ,Pathology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,STK11 ,Cancer ,Large cell neuroendocrine carcinoma of the lung ,medicine.disease ,Targeted therapy ,Oncology ,medicine ,Immunohistochemistry ,Notch ligand ,business ,Immunostaining - Abstract
Background Pulmonary large cell neuroendocrine carcinoma (LCNEC) can be subdivided in two types: the co-mutated TP53 and RB1 subtype, and the TP53 and STK11/KEAP1 mutated subtype (Derks et al. Clin Cancer Res 2018; J Thorac Oncol 2018). DLL3 is a member of the Notch ligand family and a possible treatment target for neuroendocrine carcinoma. We investigated DLL3 and NE marker expression in mutational subtypes of metastatic LCNEC. Methods Immunohistochemical (IHC) analysis for DLL3 (clone SC16.65) was performed on 94 pathological reviewed pretreatment stage IV LCNEC. Samples were scored positive if ≥1% tumor cells showed cytoplasmic or dotlike DLL3 immunostaining. Also an H-score was calculated by multiplying intensity by percentage of positive cells. Targeted next generation sequencing (TP53, RB1, STK11, KEAP1) could be performed in 66 patients. Results DLL3 was expressed in 70/94 (75%) LCNEC, 56 of which showed cytoplasmic immunostaining. 37/70 (53%) samples had an H-score>100. DLL3 staining was more often seen in STK11 and/or KEAP1 mutated LCNEC (13/14;93%) than in tumors with wildtype STK11/KEAP1 (36/52;69%) (trend;p=0.093). In addition, DLL3 positivity was associated with expression of ≥2 NE-markers (64/79 LCNEC (81%) vs 3/8 (37%) tumors with Conclusions A high percentage (75%) of stage IV LCNEC shows cytoplasmatic DLL3 epression in association with NE markers, half of which with H-scores>100. Interestingly, DLL3 positivity was observed in almost all STK11/KEAP1 mutated LCNEC, which is in agreement with recent data (George et al. Nat Commun 2018). It thus might be worthwhile to investigate the efficacy of DLL3 targeted therapy in LCNEC. Citation Format: Ernst-Jan M. Speel, Bregtje C. Hermans, Jules L. Derks, Erik Thunnissen, Robert Jan van Suylen, Michael A. den Bakker, Harry J. Groen, Egbert F. Smit, Ronald A. Damhuis, Esther C. van den Broek, Cecile M. Stallinga, Guido M. Roemen, Anne-Marie C. Dingemans. A high percentage of LCNEC shows DLL3 expression in association with molecular subtypes and neuroendocrine markers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 487.
- Published
- 2019
8. Abstract 2969: The antiviral agent Cidofovir induces DNA damage and mitotic catastrophe in HPV-positive and -negative head and neck squamous cell carcinomas in vitro
- Author
-
Ernst-Jan M. Speel, Femke Verhees, Dion Legemaate, Robin Jacobs, Wisse E. Haakma, Mat Rousch, and Bernd Kremer
- Subjects
Cancer Research ,Oncology - Abstract
Objectives: Cidofovir (CDV) is an antiviral agent with anti-proliferative properties and is suggested as treatment option in head and neck squamous cell carcinoma (HNSCC) patients to improve outcome and quality of life. The mechanisms underlying the effectivity of CDV are not completely understood. The aim of our study was to investigate the efficacy of CDV in HPV-positive and -negative HNSCC cell lines in vitro and whether it is caused by a difference in response to DNA damage. Materials and methods: Upon CDV treatment of HPV-positive and -negative HNSCC-, uterine cervical carcinoma (UCC)- and immortalized NOK- cell lines, cell viability was assessed with a MTT assay. Accumulation of DNA double strand breaks (DSBs) and activation of the DNA repair pathway were analyzed using immunofluorescence (IF) and Western blotting (WB), respectively. Apoptosis was detected by cleaved-PARP (WB) and mitotic catastrophe by phospho-Aurora Kinase and Cyclin B1 (IF). Results: All cell lines responded to CDV. Treatment resulted in γ-H2AX accumulation and upregulation of DNA repair proteins, especially in the HPV-positive cells. CDV did not induce PARP cleavage but induced Cyclin B1 expression. Phospho-Aurora Kinase immunostaining showed a decrease in number of mitoses but an increase in aberrant mitoses suggesting mitotic catastrophe upon CDV treatment. Conclusion: CDV inhibits cell growth in HPV-positive and -negative HNSCC and UCC cell lines which was more profound in HPV-positive cell lines. CDV treated cells showed accumulation of DNA DSBs. Although the DNA repair was activated, apoptosis did not occur. Rather our data indicate the occurrence of mitotic catastrophe. Citation Format: Ernst-Jan M. Speel, Femke Verhees, Dion Legemaate, Robin Jacobs, Wisse E. Haakma, Mat Rousch, Bernd Kremer. The antiviral agent Cidofovir induces DNA damage and mitotic catastrophe in HPV-positive and -negative head and neck squamous cell carcinomas in vitro [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2969.
- Published
- 2019
9. Early B-Cell Differentiation in Merkel Cell Carcinomas: Clues to Cellular Ancestry
- Author
-
Axel zur Hausen, Dorit Rennspiess, Anna Kordelia Kurz, Ernst-Jan M. Speel, Véronique Winnepenninckx, MUMC+: DA Klinische Pathologie (5), Pathologie, Genetica & Celbiologie, and RS: GROW - School for Oncology and Reproduction
- Subjects
Male ,Cancer Research ,Skin Neoplasms ,Cell of origin ,Cell ,Immunoglobulins ,Biology ,DNA Nucleotidylexotransferase ,medicine ,Humans ,B cell ,Aged ,Aged, 80 and over ,B-Lymphocytes ,Polyomavirus Infections ,Merkel cell carcinoma ,Precursor Cells, B-Lymphoid ,PAX5 Transcription Factor ,Cell Differentiation ,Middle Aged ,medicine.disease ,Carcinoma, Merkel Cell ,Tumor Virus Infections ,medicine.anatomical_structure ,Merkel cell polyomavirus ,Oncology ,Terminal deoxynucleotidyl transferase ,Immunology ,Monoclonal ,Cancer research ,Female ,PAX5 ,Merkel cell - Abstract
Merkel cell carcinoma (MCC) is a highly malignant neuroendocrine nonmelanoma skin cancer, which is associated with the Merkel cell polyoma virus (MCPyV). Recently, expression of the terminal deoxynucleotidyl transferase (TdT) and the paired box gene 5 (PAX 5) has been consistently reported in the majority of MCCs. We tested 21 MCCs for the expression of MCPyV, TdT, PAX5, IgG, IgM, IgA, kappa, and lambda by immunohistochemistry and assessed IgH and Igk rearrangement in all 21 MCCs. All of the MCCs revealed specific expression of PAX5 and 72.8% of the MCCs expressed TdT. In addition, most of the MCCs revealed specific expression of one or more Ig subclasses and kappa or lambda. One MCC did reveal monoclonal IgH and Igk rearrangement next to two other MCCs showing Igk rearrangement. As coexpression of TdT and PAX5 under physiologic circumstances is restricted to pro/pre- and pre-B cells we propose, on the basis of our results, that the cell of origin of MCCs is a pro/pre- or pre-B cell rather than the postmitotic Merkel cells. MCPyV infection and transformation of pro-/pre-B cells are likely to induce the expression of simple cytokeratins as has been shown for SV40 in other nonepithelial cells. This model of cellular ancestry of MCCs might impact therapy and possibly helps to understand why approximately 20% of MCCs are MCPyV-negative. Cancer Res; 73(16); 4982–7. ©2013 AACR.
- Published
- 2013
10. Abstract 5358: Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma
- Author
-
Akram Ghantous, James McKay, Catherine Voegele, Joachim H. Clement, Elisabeth Brambilla, Cyrille Cuenin, Noémie Leblay, Luca Roz, Theo Giffon, Janine Altmueller, David Marin, Paolo Graziano, Alex Soltermann, Geoffroy Durand, Juan Sandoval, Matthieu Foll, Sylvie Lantuejoul, Zdenko Herceg, Ernst-Jan M. Speel, Jules L. Derks, Lynnette Fernandez-Cuesta, Lucia Anna Muscarella, Amelie Chabrier, Nicolas Girard, Nicolas Alcala, Philippe Lorimier, Anne-Claire Toffart, Tiffany M. Delhomme, Gavin M. Wright, John K. Field, Peter Nuernberg, Odd Terje Brustugun, and Joerg Saenger
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,ARID1A ,Cancer ,Biology ,medicine.disease ,03 medical and health sciences ,Exact test ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,DNA methylation ,medicine ,Multi omics ,MEN1 ,Large-cell neuroendocrine carcinoma ,Exome sequencing - Abstract
Pulmonary grade-1 typical (TC) and grade-2 atypical (AC) carcinoids share molecular characteristics with grade-3 large-cell neuroendocrine carcinoma (LCNEC) despite the distinct clinical behaviors. Most carcinoids can be surgically resected, however, limited treatment options exist for metastatic disease, present in 10-23% of TC and 40-50% of AC. Comprehensive genomic studies could help identify better therapeutic opportunities, novel diagnostic markers, and provide insight on the mechanisms responsible for the increased aggressiveness of AC versus TC. Such studies are rare due to the limited availability of suitable material. We have established a multi-center collaboration that has given us access to a unique collection of samples. We have already characterized 40 TC and 60 LCNEC genomes/exomes, and 61 TC, 8 AC and 69 LCNEC trancriptomes (published data). In the present study, we have performed whole-exome and transcriptome sequencing on 20 AC patients. Methylation data from 850K Illumina arrays were also generated for these samples, and for a subset of 20 TC and 20 LCNEC previously mentioned. When comparing the mutational data on AC with that of TC and LCNEC, we have found that similar to TC, AC harbor recurrent alterations in chromatin remodeling genes (such as MEN1 and ARID1A). They also carry alterations in genes involved in other cancer-related pathways (based on STRING), such as cell motility and cell death explaining their more aggressive phenotype. Integrative clustering analysis (MOFA and iCLUSTER) based on expression and methylation data tends to classify carcinoids into four groups: groups 1 and 2 are mostly composed of females with TC, and differ by their age composition and smoking status (Fisher's exact test p=0.008 and 0.03, respectively). Groups 3 and 4 are mostly composed of males with AC (Fisher's exact test for tumor type p=8x10-5). When including the LCNEC data, the samples from group 3 cluster with LCNEC, suggesting that AC can display a variety of expression and methylation patterns that may be linked to aggressiveness. This result was supported by the better survival of groups 1 and 2 compared to groups 3 and 4 (log-rank p=0.02), for which survival was similar to that of patients with LCNEC. Here, we present for the first time: (i) a multi-omics study on AC; (ii) the methylome characterization of TC, AC, and LCNEC; and (iii) the results of a comparative analysis of TC, AC, and LCNEC based on their molecular characteristics. We have identified the genes and pathways that might explain the progression from low-grade TC to intermediate-grade AC. Our expression and methylation data also supports the existence of a “super-AC” group, which clusters with LCNEC. Finally, we have identified a panel of molecular alterations that may help pathologist distinguishing between these three entities. NL and NA contributed equally. LFC and MF jointly supervised this work. Citation Format: Noémie Leblay, Nicolas Alcala, David Hervás Marin, Tiffany M. Delhomme, Théo Giffon, Akram Ghantous, Amélie Chabrier, Cyrille Cuenin, Janine Altmueller, Geoffroy Durand, Catherine Voegele, Philippe Lorimier, Anne-Claire Toffart, Jules Derks, Odd Terje Brustugun, Joachim H. Clement, Joerg Saenger, John K. Field, Alex Soltermann, Gavin M. Wright, Luca Roz, Lucia Anna Muscarella, Paolo Graziano, Zdenko Herceg, Ernst-Jan Speel, Peter Nuernberg, James McKay, Nicolas Girard, Sylvie Lantuejoul, Juan Sandoval, Elisabeth Brambilla, Matthieu Foll, Lynnette Fernandez-Cuesta. Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5358.
- Published
- 2018
11. Abstract 828: Methylation status of HPV16 E2-binding sites identifies subtypes of HPV-associated oropharyngeal squamous cell carcinomas
- Author
-
Simon F. Preuss, Jutta Kolligs, Svetlana Vinokurova, Simon Kalteis, Nadine C. Olthof, Ernst-Jan M. Speel, Justo Lorenzo Bermejo, Miriam Reuschenbach, Christian U. Huebbers, Steffen Wagner, Jens Peter Klussmann, Magnus von Knebel Doeberitz, Elena-Sophie Prigge, and Bernd Kremer
- Subjects
Cancer Research ,Viral Oncogene ,Cancer ,Methylation ,Biology ,medicine.disease ,medicine.disease_cause ,Molecular biology ,Genome ,Oncology ,CpG site ,Gene duplication ,DNA methylation ,medicine ,Carcinogenesis - Abstract
Background: The viral E2 protein is a transcriptional repressor of the HPV oncogenes E6/E7 and loss of E2 function is considered a key step in carcinogenesis. Integration of HPV into the host genome may disrupt the E2 gene. Furthermore, methylation of CpG dinucleotides in E2 binding sites (E2BSs) in the HPV upstream regulatory region (URR) may interfere with transcriptional repression of E6 and E7 by the E2 protein. We hypothesized that CpG methylation of the E2BS is found in a proportion of HPV16-associated oropharyngeal squamous cell cancers (OPSCC) in association with E2 gene integrity and viral integration. Methods: Methylation of 10 CpGs within the URR, encompassing E2BSs 1, 2, 3 and 4, was quantitatively analyzed by bisulfite pyrosequencing in 57 HPV16-associated OPSCC. E2 status was analyzed by gene amplification and quantitative real-time RT-PCR. Viral integration was determined by integration-specific PCR methods. Results: Three subgroups with differential E2BSs3 and 4 methylation were identified: a) complete methylation (>80%) associated with presence of integrated HPV genomes with intact E2 gene, b) intermediate methylation levels (20-80%) with predominantly episomal HPV genomes with intact E2, and c) no methylation ( Conclusions: E2BSs3 and 4 methylation in oropharyngeal cancers with episomal HPV and integrated HPV with intact E2 gene might explain deregulated viral oncogene expression in the presence of E2. The methylation level appears to be of prognostic significance for patients with HPV-associated OPSCC. Citation Format: Ernst-Jan M. Speel, Miriam Reuschenbach, Christian U. Huebbers, Elena-Sophie Prigge, Justo L. Bermejo, Simon Kalteis, Simon Preuss, Jutta Kolligs, Nadine C. Olthof, Bernd Kremer, Steffen Wagner, Jens P. Klussmann, Svetlana Vinokurova, Magnus von Knebel Doeberitz. Methylation status of HPV16 E2-binding sites identifies subtypes of HPV-associated oropharyngeal squamous cell carcinomas. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 828. doi:10.1158/1538-7445.AM2015-828
- Published
- 2015
12. Early B-Cell Differentiation in Merkel Cell Carcinomas: Clues to Cellular Ancestry
- Author
-
zur Hausen, Axel, primary, Rennspiess, Dorit, additional, Winnepenninckx, Veronique, additional, Speel, Ernst-Jan, additional, and Kurz, Anna Kordelia, additional
- Published
- 2013
- Full Text
- View/download PDF
13. Abstract 4775: HPV16-E2/E4, -E6 and -E7 genes and HPV-disrupted human genes show large variation in expression levels in OSCC independent of the viral physical status.
- Author
-
Klussmann, Jens P., primary, Olthof, Nadine C., additional, Huebbers, Christian U., additional, Kolligs, Jutta, additional, Ramaekers, Frans CS, additional, Preuss, Simon, additional, Drebber, Uta, additional, Vucic, Emily, additional, Lam, Wan, additional, Kremer, Bernd, additional, and Speel, Ernst Jan, additional
- Published
- 2013
- Full Text
- View/download PDF
14. Abstract 2380: Reduced CD44 and OTP gene expression are strong indicators of poor prognosis in pulmonary carcinoids.
- Author
-
Swarts, Dorian RA, primary, Henfling, Mieke, additional, van Neste, Leander, additional, van Suylen, Robert J., additional, Dingemans, Anne-Marie, additional, Dinjens, Winand NM, additional, Haesevoets, Annick, additional, Rudelius, Martina, additional, Thunnissen, Erik, additional, Volante, Marco, additional, van Criekinge, Wim, additional, van Engeland, Manon, additional, Ramaekers, Frans CS, additional, and Speel, Ernst-Jan M., additional
- Published
- 2013
- Full Text
- View/download PDF
15. Abstract 4775: HPV16-E2/E4, -E6 and -E7 genes and HPV-disrupted human genes show large variation in expression levels in OSCC independent of the viral physical status
- Author
-
Nadine C. Olthof, Jens Peter Klussmann, Wan L. Lam, Bernd Kremer, Uta Drebber, Simon F. Preuss, Ernst-Jan M. Speel, Emily A. Vucic, Frans C. S. Ramaekers, Jutta Kolligs, and Christian U. Huebbers
- Subjects
Genetics ,Cancer Research ,medicine.diagnostic_test ,Oncogene ,Cell ,Biology ,Virus ,medicine.anatomical_structure ,Oncology ,Transcription (biology) ,Gene expression ,Cancer research ,medicine ,Human genome ,Gene ,Fluorescence in situ hybridization - Abstract
Infection with high-risk human papillomavirus (HPV) type 16 is an independent risk factor for the development of oropharyngeal squamous cell carcinomas (OSCC). However, it is unclear whether viral integration is an essential hallmark in the carcinogenic process of OSCC and whether HPV integration correlates to the level of viral gene transcription and influences the expression of disrupted genes. HPV16 integration sites were assessed in 75 patients with HPV16-DNA- and p16INK4A-positive OSCC using Detection of Integrated Papillomavirus Sequences (DIPS)- as well as Amplification of Papillomavirus Oncogene Transcripts (APOT)-PCR. Quantitative RT-PCR assays were carried out to determine the viral E2/E4, E6 and E7 gene expression levels. Expression levels of 7 human genes disrupted by the virus were extracted from mRNA expression profiling data of 32 OSCC. Nuclear localization of HPV16 was visualized using Fluorescence In Situ Hybridization (FISH) in 59 OSCC, and corresponding viral copy numbers were assessed by quantitative RT-PCR in 61 tumors. We identified 37 HPV16-human fusion products indicating viral integration in 29 (39%) OSCC. In the remaining tumors (61%) only episome-derived PCR products were detected. When comparing OSCC with or without an integration-derived fusion product, we neither found significant differences in the mean expression of the viral genes E2/E4, E6 and E7, the nuclear FISH staining patters nor the viral copy numbers per cell. The expression of the HPV-invaded genes also did not significantly differ when comparing the expression in the affected tumor with the expression of that gene in either group of OSCC. In conclusion, our data do not support the hypothesis that integration affects the levels of viral and/or HPV-disrupted human gene transcripts. Thus constitutive, rather than a high level, of expression of oncogene transcripts appears to be required in HPV-related OSCC. Citation Format: Jens P. Klussmann, Nadine C. Olthof, Christian U. Huebbers, Jutta Kolligs, Frans CS Ramaekers, Simon Preuss, Uta Drebber, Emily Vucic, Wan Lam, Bernd Kremer, Ernst Jan Speel. HPV16-E2/E4, -E6 and -E7 genes and HPV-disrupted human genes show large variation in expression levels in OSCC independent of the viral physical status. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4775. doi:10.1158/1538-7445.AM2013-4775
- Published
- 2013
16. Abstract 2380: Reduced CD44 and OTP gene expression are strong indicators of poor prognosis in pulmonary carcinoids
- Author
-
Erik Thunnissen, Ernst-Jan M. Speel, Robert J. van Suylen, Martina Rudelius, Leander Van Neste, Dorian Ra Swarts, Wim Van Criekinge, Winand N.M. Dinjens, Anne-Marie C. Dingemans, Mieke Henfling, Frans C. S. Ramaekers, Manon van Engeland, Marco Volante, and Annick Haesevoets
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Pathology ,biology ,business.industry ,CD44 ,Cancer ,Neuroendocrine tumors ,Gene mutation ,medicine.disease ,Internal medicine ,Gene expression ,medicine ,biology.protein ,Immunohistochemistry ,Histopathology ,business ,Immunostaining - Abstract
Purpose: Pulmonary carcinoids are well-differentiated neuroendocrine tumors showing usually a favorable prognosis. However, there is a risk for late recurrence and/or distant metastasis. Because histological classification in typical and atypical (AC) carcinoids is difficult and its reliability to predict disease outcome varies, we evaluated three genes as potential prognostic markers, i.e., OTP, CD44 and RET. Methods: These genes were analyzed in 56 frozen carcinoids by quantitative RT-PCR. RET was further studied by methylation and mutation analysis. Immunohistochemistry for CD44 and OTP protein expression was performed on 292 carcinoids. Results: Low mRNA expression levels of CD44 (p=1.3e-5) and OTP (p=0.012), and high levels of RET (p=0.0025), were strongly associated with a low 20-year survival of carcinoid patients. High RET expression was not related to promoter hypomethylation or gene mutations. A direct link between gene expression and protein levels was confirmed for CD44 and OTP, but not for RET. Within all carcinoids as well as ACs, absence of CD44 protein was significantly associated with low 20-year survival (p=8.6e-5 and p=0.00015, respectively). The absence of nuclear OTP followed by complete loss of expression was also significantly associated with unfavorable disease outcome in all carcinoids (p=2.9e-5). Multivariate analysis revealed that CD44 and OTP immunostaining combined with histopathology is the optimal indicator for patient outcome. Conclusions: Our study indicates that CD44 and OTP are strong indicators of poor outcome. We therefore argue for implementation of these markers in routine diagnostics in addition to histopathology to improve subclassification of pulmonary carcinoids into prognostically relevant categories. Citation Format: Dorian RA Swarts, Mieke Henfling, Leander van Neste, Robert J. van Suylen, Anne-Marie Dingemans, Winand NM Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, Wim van Criekinge, Manon van Engeland, Frans CS Ramaekers, Ernst-Jan M. Speel. Reduced CD44 and OTP gene expression are strong indicators of poor prognosis in pulmonary carcinoids. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2380. doi:10.1158/1538-7445.AM2013-2380
- Published
- 2013
17. Abstract 557: Fluorescence in situ hybridization versus qPCR as means to detect Merkel cell polyomavirus in Merkel cell carcinoma
- Author
-
Haugg, Anke M., primary, Rennspiess, Dorit, additional, zur Hausen, Axel, additional, Speel, Ernst-Jan M., additional, Cathomas, Gieri, additional, Becker, Jürgen C., additional, and Schrama, David, additional
- Published
- 2012
- Full Text
- View/download PDF
18. Abstract LB-386: The NuRD complex cooperates with DNMTs to maintain silencing of colorectal tumor suppressor genes.
- Author
-
Cai, Yi, primary, Geutjes, Ernst-Jan, additional, Roepman, Paul, additional, Yu, Li-Rong, additional, Blijswijk, Janneke V., additional, Wang, Wei, additional, Mohammad, Helai, additional, de Rink, Iris, additional, Baylin, Stephen, additional, and Bernards, Rene, additional
- Published
- 2012
- Full Text
- View/download PDF
19. Abstract 2255: Diagnostic and prognostic value of oncogenic human papillomavirus in patients with carcinoma of unknown primary of the neck
- Author
-
Speel, Ernst-Jan M., primary, Straetmans, Jos M.J.A.A., additional, Vent, Julia, additional, Mujagic, Zlatan, additional, Henfling, Mieke, additional, Haesevoets, Annick, additional, Haidl, B, additional, Huebbers, Christian U., additional, Ramaekers, Frans CS, additional, Kremer, Bernd, additional, and Klussmann, Jens P., additional
- Published
- 2011
- Full Text
- View/download PDF
20. Abstract 2717: Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia cells by fluorescence in situ hybridization (FISH)
- Author
-
Speel, Ernst-Jan M., primary, Haugg, Anke, additional, Pantulu, Naga Deepa, additional, Pallasch, Christian, additional, Kurz, Anna K., additional, Kassem, Ahmad, additional, Frenzel, Lukas, additional, Sodenkamp, Sebastian, additional, Kvasnicka, Hans M., additional, Wendtner, Clemens, additional, and Zur Hausen, Axel, additional
- Published
- 2011
- Full Text
- View/download PDF
21. Abstract 4122: Multi-center validation of a lymph node metastasis gene-expression signature for head and neck squamous cell carcinomas
- Author
-
Speel, Ernst-Jan M., primary, Leusink, Frank K.J., additional, van Hooff, Sander R., additional, Kummer, J Alain, additional, van Diest, Paul J., additional, Koole, Ronald, additional, Roepman, Paul, additional, van den Brekel, Michiel W.M., additional, Merkx, Thijs A., additional, Jansen, Jeroen C., additional, Schuuring, Ed M.D., additional, Brakenhoff, Ruud H., additional, Baatenburg de Jong, Robert J., additional, Slootweg, Piet J., additional, Holstege, Frank C.P., additional, and Takes, Robert P., additional
- Published
- 2011
- Full Text
- View/download PDF
22. Abstract 557: Fluorescence in situ hybridization versus qPCR as means to detect Merkel cell polyomavirus in Merkel cell carcinoma
- Author
-
David Schrama, Jürgen C. Becker, Ernst-Jan M. Speel, Anke M. Haugg, Gieri Cathomas, Axel zur Hausen, and Dorit Rennspiess
- Subjects
Cancer Research ,biology ,Merkel cell carcinoma ,Merkel cell polyomavirus ,Cancer ,biology.organism_classification ,medicine.disease ,Virology ,Virus ,medicine.anatomical_structure ,Oncology ,Viral replication ,Cell culture ,medicine ,Primer (molecular biology) ,Merkel cell - Abstract
Background: Merkel cell polyoma virus (MCPyV) is detected in 80% of Merkel cell carcinomas (MCC). The clonal integration and tumor specific mutations in the large T Antigen (LTAg) gene strongly implicate an oncogenic impact of the virus. To date the relationship between the viral presence and cancer induction, development or clinical prognosis is discussed controversial. Yet almost all studies are based on quantitative virus detection e.g. PCR or qPCR. Material and Method: In order to gain additional information about the quality of the viral presence on the single cell level we performed FISH analysis of formalin fixed and paraffin embedded (FFPE) MCCs (n= 62) on tissue micro arrays (TMA), determined the FISH pattern and correlated the results of the FISH analysis with the qPCR data. We grouped the MCCs according to different FISH evaluations and correlated them with the respective qPCR data on the basis of a determined cut-off. MCPyV FISH was established using the MKL-1 cell line which harbors integrated copies of MCPyV DNA. For MCPyV-qPCR the LT3 primer pair was used on whole tissue sections. Results: MCPyV-FISH on FFPE MKL-1 cells revealed punctate signals compatible with viral integration. The MCPyV FISH positive MCC cores (76%) mainly revealed two different signal patterns: a punctate pattern (85%) which correlated with a moderate relative viral presence and in some areas the punctate pattern was combined with a diffuse pattern (15%) indicating the episomal presence of the virus which is linked to viral replication. If a pattern mixture was seen this was associated with very high qPCR values. Comparing MCPyV FISH and qPCR data the results correlated highly with 83 % in the MCPyV positive evaluated group, whereas the negative group showed a concordance of 93 %. The mean of the qPCR values of all MCPyV positive cores differed significantly from the negative cores (p= 0.0076). The FISH signals were in some tumor areas from the same patient heterogenic in intensity, pattern and localization. Conclusion: While the qPCR using the LT3 primer pair was highly sensitive to detect MCPyV sequences in the respective MCC cases, the MCPyV FISH analysis highly concordantly revealed the quality of the viral presence, i.e. viral integration or episomal presence and morphological sublocalization in the tissues. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 557. doi:1538-7445.AM2012-557
- Published
- 2012
23. Abstract LB-386: The NuRD complex cooperates with DNMTs to maintain silencing of colorectal tumor suppressor genes
- Author
-
Paul Roepman, Li-Rong Yu, Helai P. Mohammad, Wei Wang, Iris de Rink, Ernst-Jan Geutjes, René Bernards, Yi Cai, Stephen B. Baylin, and Janneke V. Blijswijk
- Subjects
Cancer Research ,Histone ,Oncology ,Wnt signaling pathway ,Cancer research ,DNMT1 ,biology.protein ,Gene silencing ,Epigenetics ,Biology ,DNA methyltransferase ,Mi-2/NuRD complex ,Chromatin - Abstract
Many Tumor Suppressor Genes (TSGs) are silenced through synergistic layers of epigenetic regulation including abnormal DNA hypermethylation of promoter CpG islands, repressive chromatin modifications and enhanced nucleosome deposition over transcription start sites. Many of the protein complexes responsible for silencing of such TSGs remain to be identified. A subset of silenced TSGs controlling key regulatory signaling pathways in colorectal cancer cells can be partially reactivated by in cells disrupted for the DNA methyltransferase 1 and 3B (DNMT1 and 3B) or by DNMT inhibitors (DNMTi). Herein, we used proteomic and functional genomic approaches to identify additional proteins that cooperate with DNMTs in silencing these key silenced TSGs in colon cancer cells. We discovered that DNMTs and the core components of the NuRD nucleosome remodeling complex, chromo domain helicase DNA-binding protein 4 (CHD4), histone deacetylases 1 and 2 (HDAC1 and 2), occupy the promoters of several of these key hypermethylated TSGs and physically and functionally interact to maintain their silencing. Consistent with this, we find an inverse relationship between expression of HDAC1 and 2 and these TSGs in a large panel of primary colorectal tumors. We demonstrate that this DNMT-NuRD complex maintains the silencing of several negative regulators of the WNT signaling pathway. We find that depletion of CHD4 is synthetic lethal with DNMT inhibition in correlation with reactivation of TSGs, suggesting that their combined inhibition may be beneficial for the treatment of colon cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-386. doi:1538-7445.AM2012-LB-386
- Published
- 2012
24. Abstract 5368: Increase in viral load, viral integration and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV MLPA-assay
- Author
-
Speel, Ernst-Jan M., primary, Theelen, Wendy, additional, Herfs, Michael, additional, Reijans, Martin, additional, Simons, Guus, additional, Meulemans, Els V., additional, Baldewijns, Marcella M., additional, Ramaekers, Frans CS, additional, Somja, Joan, additional, Delvenne, Philippe, additional, and Hopman, Anton HN, additional
- Published
- 2010
- Full Text
- View/download PDF
25. Abstract 5352: A high percentage of Merkel cell carcinomas is biologically associated with Merkel cell polyomavirus
- Author
-
Speel, Ernst-Jan M., primary, Schmidt, Andreia, additional, Baumann, M, additional, Haesevoets, Annick, additional, Diebold, J, additional, Hofmann, P, additional, Kurrer, Michael, additional, Willi, N, additional, Offner, F, additional, Sauter, Guido, additional, Zsikla, V, additional, and Cathomas, Gieri, additional
- Published
- 2010
- Full Text
- View/download PDF
26. Abstract 5720: Chromosomal instability predicts the progression of premalignant oral lesions
- Author
-
Hamers, Rinske MPT, primary, Siebers, Theke JH, additional, Haesevoets, Annick, additional, Zwijnenberg, Iris R., additional, Voogd, Adri C., additional, Ramaekers, Frans CS, additional, Kremer, Bernd, additional, Merkx, Thijs MAW, additional, Slootweg, Pieter J., additional, and Speel, Ernst-Jan M., additional
- Published
- 2010
- Full Text
- View/download PDF
27. Abstract 2255: Diagnostic and prognostic value of oncogenic human papillomavirus in patients with carcinoma of unknown primary of the neck
- Author
-
Ernst-Jan M. Speel, Bernd Kremer, Zlatan Mujagic, Annick Haesevoets, Jens Peter Klussmann, Christian U. Huebbers, B Haidl, Jos M.J.A.A. Straetmans, Mieke Henfling, Frans C. S. Ramaekers, and Julia Vent
- Subjects
Oncology ,Thorax ,Cancer Research ,medicine.medical_specialty ,Pathology ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Cancer ,Neck dissection ,medicine.disease ,Primary tumor ,Curettage ,Internal medicine ,medicine ,Carcinoma ,business ,Survival rate ,Fluorescence in situ hybridization - Abstract
Objective. To date, there is no consensus on the optimal diagnostic and therapeutic strategy for patients with carcinoma of unknown primary (CUP) of the neck. These tumors are heterogeneous in their clinical and biological characteristics, and a pre-operative prognostic marker is desirable to optimize therapy and improve outcome and survival. Human papillomavirus (HPV) is an etiologic factor in a subgroup of head and neck squamous cell carcinomas and has been identified as a significant prognostic biomarker. We sought to determine if HPV also may add relevant information on the origin and prognosis of these tumors. Material and method. 47 patients (mean age 58.7 years; 40 men, 7 women) presenting with CUP of the neck between 1994 and 2008 in Cologne were examined by standard diagnostic procedures including radiological imaging of the head, neck, thorax and abdomen, positron emission tomography (PET), panendoscopy, curettage of the nasopharynx, bilateral tonsillectomy and blind probes of the base of tongue. All patients were surgically treated with neck dissection of the diseased neck as well as adjuvant chemoradiation. The mean follow up time was 34 months. Formaldehyde-fixed, paraffin-embedded tissue specimens of the 47 metastases were examined retrospectively by means of p16INK4A immunohistochemistry, HPV-specific PCR and fluorescence in situ hybridization. Results were correlated with clinical follow-up data. Results. Oncogenic HPV was present in 12/47 (26%) metastases (10 with HPV 16), which showed also p16INK4A overexpression. In 42% of CUP patients the primary tumor was discovered during follow-up. A significant correlation between HPV positivity and later detection of the primary tumor in the oropharynx was found (p=0.038). Moreover, patients with a p16INK4A- (13/47) or HPV-positive tumor had a more favorable overall 5-year survival rate then p16INK4A- and HPV-negative tumors (69% vs 33%, p=0.05; 65% vs 37%, p=0.093; respectively). Conclusion. HPV is present in a quarter of neck metastases of CUP patients and the presence of oncogenic HPV and p16INK4A expression can serve to locate the primary tumor in the oropharynx. In addition, both biomarkers are indicators of a favorable prognosis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2255. doi:10.1158/1538-7445.AM2011-2255
- Published
- 2011
28. Abstract 2717: Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia cells by fluorescence in situ hybridization (FISH)
- Author
-
Sebastian Sodenkamp, Naga Deepa Pantulu, Christian P. Pallasch, Anke Haugg, Hans Michael Kvasnicka, Lukas P. Frenzel, Ernst-Jan M. Speel, Clemens M. Wendtner, Anna Kordelia Kurz, Ahmad Kassem, and Axel zur Hausen
- Subjects
Cancer Research ,medicine.diagnostic_test ,biology ,Colorectal cancer ,Chronic lymphocytic leukemia ,Merkel cell polyomavirus ,Cancer ,medicine.disease ,biology.organism_classification ,Virology ,Virus ,medicine.anatomical_structure ,Oncology ,medicine ,Cancer research ,Immunohistochemistry ,Merkel cell ,Fluorescence in situ hybridization - Abstract
Background: Merkel cell polyomavirus (MCPyV) is detected in approximately 80% of Merkel cell carcinomas (MCC). A number of previous studies have shown that MCC patients are at a significantly increased risk to develop chronic lymphocytic leukemia (CLL) and vice versa. Until recently, clonal integration and truncating mutations of the Large T antigen (LTAg) of MCPyV were restricted to MCC. We have recently reported the presence of the MCPyV in highly purified tumor cells of CLL (n = 19/70, 27.1%) (Blood. 2010 Sep 3). Of these, six revealed a novel 246 bp deletion in the helicase gene of the LTAg. The presence of MCPyV was confirmed by immunohistochemistry. Material and Method: Here we aimed to determine the presence of MCPyV by fluorescence in situ hybridization (FISH) analysis in CLL cells in order to evaluate whether MCPyV was integrated or episomal. For this purpose we performed FISH analysis as previously described (Int J Cancer. 2005, 115:419-428) using the MCPyV genome as FISH probe. We tested 2 of the previously reported MCPyV positive CLL cases (EDTA decalcified bone marrow trephines) and MCPyV-positive MCC (n = 5). In addition, we tested MCPyV-negative tumors, e.g. breast and colon cancers. All tissues were formalin-fixed and paraffin-embedded. Results: Specific MCPyV DNA by FISH analysis was detected in the nuclei of MCPyV-positive CLL and MCC cells. In contrast to particularly punctate FISH signals in MCC indicating viral integration, the nuclear FISH signals of the CLL cases revealed especially granular signals, indicative for integrated MCPyV DNA together with transcribed viral RNA (Int J Cancer. 2008, 122:2656-2664). No signals were obtained by MCPyV FISH in breast or colon cancer specimens. Conclusion: The specific detection of MCPyV in CLL cells further supports our previous report of a possible involvement of MCPyV in a significant subset of CLL. The specific but rather granular nuclear FISH signals in MCPyV positive CLL cells needs further study to evaluate if it is also generated by co-existing episomal virus copies, by viral RNA or by the decalcification process. In addition, more CLL cases will be analyzed for the presence of MCPyV. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2717. doi:10.1158/1538-7445.AM2011-2717
- Published
- 2011
29. Abstract 5720: Chromosomal instability predicts the progression of premalignant oral lesions
- Author
-
Iris Zwijnenberg, Théke J.H. Siebers, Frans C. S. Ramaekers, Bernd Kremer, Rinske Mpt Hamers, Ernst-Jan M. Speel, Thijs Maw Merkx, Pieter J. Slootweg, Adri C. Voogd, and Annick Haesevoets
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Cancer ,medicine.disease ,medicine.anatomical_structure ,Oncology ,Chromosome instability ,medicine ,Carcinoma ,Histopathology ,Oral mucosa ,business ,Survival rate ,Fluorescence in situ hybridization ,Moderate Dysplasia - Abstract
A major dilemma in the management of patients with precursor lesions of the oral mucosa lies in deciding which lesions will progress into carcinoma. Because a strong association between histological differentiation and clinical prognosis is lacking, the aim of this study was to evaluate the value of chromosomal instability (CIN) detected by fluorescence in situ hybridization (FISH) for the identification of oral premalignant lesions at risk for progression. We examined a series of premalignant oral mucosa lesions of 106 patients by means of FISH on paraffin-embedded tissue sections using biotin- and digoxigenin-labeled probes specific for the centromeric regions of chromosomes 1 and 7. CIN was indicated by the presence of chromosome imbalances and/or polyploidization for chromosomes 1 and 7. Results were correlated with histopathological data as well as with clinical follow up data. The 5-year progression-free survival rate was 83%. Outcome of routine histopathology did only predict malignant progression when comparing severe dysplasia with lower stage precursor lesions (hyperplasia, mild en moderate dysplasia) (p In conclusion, tumorigenesis of the oral mucosa is associated with the development of CIN, which can reliably identify lesions at risk for progression. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 5720.
- Published
- 2010
30. Abstract 5368: Increase in viral load, viral integration and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV MLPA-assay
- Author
-
Marcella M. Baldewijns, Els V. Meulemans, Ernst-Jan M. Speel, Wendy Theelen, Philippe Delvenne, Guus Simons, Michael Herfs, Frans C. S. Ramaekers, Martin Reijans, Joan Somja, and Anton H. N. Hopman
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Telomerase ,medicine.diagnostic_test ,business.industry ,Cell ,Cancer ,medicine.disease ,Molecular biology ,medicine.anatomical_structure ,Real-time polymerase chain reaction ,Internal medicine ,medicine ,Multiplex ligation-dependent probe amplification ,Risk factor ,business ,Viral load ,Fluorescence in situ hybridization - Abstract
Oncogenic human papillomavirus (HPV) infection is the most important risk factor in cervical carcinogenesis with high viral load, viral integration into the host genome, and gain of the telomerase-related genes TERT and TERC being factors associated with progression to cancer. A recently developed multiparameter HPV MLPA-assay (Theelen et al. Int J Cancer 2009, Epub Aug 26) that allows the simultaneous assessment of these factors was applied to a series of normal and (pre)malignant frozen uterine cervical samples, and tested for its ability to identify high grade cervical lesions with both high sensitivity and specificity. A total of 67 cervical samples from normal cervix, as well as different (pre)malignant stages was analysed by the MLPA-assay and validated by quantitative PCR, the PapilloCheck, and fluorescence in situ hybridization for the individual parameters. Only 5 out of 37 (14%) normal samples or low grade cervical lesions (CIN1 and condyloma) showed either a HPV16 viral load higher than 25 copies per cell, viral integration, and/or gain of one of the telomerase related genes, whereas for the high grade cervical lesions (CIN2/3 and squamous cell carcinoma) one or more of these parameters were found in 25 out of 30 cases (83%). As a result, the HPV MLPA-assay combines a sensitivity of 83% with a specificity of 86% in frozen cervical specimens, making it a valuable screening tool for cervical (pre)neoplasia. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 5368.
- Published
- 2010
31. Abstract 5352: A high percentage of Merkel cell carcinomas is biologically associated with Merkel cell polyomavirus
- Author
-
Ernst-Jan M. Speel, Felix Offner, Michael O. Kurrer, Niels Willi, Veronika Zsikla, P Hofmann, Annick Haesevoets, Joachim Diebold, Guido Sauter, Gieri Cathomas, Michele Baumann, and Andreia Schmidt
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,biology ,medicine.diagnostic_test ,Hybridization probe ,Merkel cell polyomavirus ,Cancer ,DNA virus ,biology.organism_classification ,medicine.disease ,Molecular biology ,medicine.anatomical_structure ,Oncology ,Antigen ,medicine ,Immunohistochemistry ,Merkel cell ,Fluorescence in situ hybridization - Abstract
Merkel cell polyomavirus (MCPyV) DNA has been detected by PCR in 75-100% of Merkel cell carcinomas (MCC), an aggressive neuroendocrine skin cancer. MCPyV is a 5.4 kb DNA virus that expresses tumor (T) antigen in tumor tissues. The aim of this study was to analyze which subset of MCC is biologically associated with MCPyV using various viral detection methods. Genomic DNA isolated from paraffin-embedded tissue of 61 MCC was analyzed by MCPyV-specific PCR. Using a 5kb MCPyV DNA probe, the physical status of MCPyV was determined by fluorescence in situ hybridization (FISH) using tyramide signal amplification and ApoTome microscopy. Expression of large T antigen was assessed by immunohistochemistry (IHC) using monoclonal antibody CM2B4 (kindly provided by Y. Chang). A total of 44 of 61 (72%) MCC were positive for MCPyV by PCR. 34 of these 44 cases (77%) were also positive for MCPyV by FISH and 28 (64%) showed strong nuclear large T antigen expression by IHC. In contrast, none of the 17 PCR-negative tumors showed FISH signals and only 1 case showed a weak immunostaining for large T antigen. FISH analysis showed in 16 cases (47%) tumor nuclei with a single punctate signal indicating viral integration. In 8 of these tumors also areas were observed with a granular pattern with >1 nuclear signals varying significantly in size and intensity, indicating the presence of episomal viral DNA and/or RNA. In the remaining 18 cases (53%) an exclusive granular FISH pattern was observed. Our data indicate that a subset of MCC is caused by MCPyV as determined by PCR, FISH and IHC analysis (46% is positive with all 3 detection methods). FISH and IHC showed a strong positive and negative concordance. FISH signal evaluation furthermore suggests viral integration in half of the positive MCC and a non-clonal viral persistence in the remaining positive cases. Further studies have to validate these findings and elucidate the molecular mechanisms underlying MCV-positive and -negative MCC development. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 5352.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.